查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869990

mRNA品質監測市場規模、佔有率和趨勢分析報告：按產品/服務、技術、最終用途、地區和細分市場預測（2025-2033年）

mRNA Quality Monitoring Market Size, Share & Trends Analysis Report By Product & Service, By Technology (Electrophoresis, LC-MS, PCR Techniques), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

mRNA品質監測市場摘要

2024年全球mRNA品質監測市場規模估計為12.8億美元，預計2033年將達到23.3億美元。

預計2025年至2033年間，該市場將以6.93%的複合年成長率成長。 mRNA療法和疫苗的日益普及推動了對嚴格品質監控的需求，以確保產品的安全性、有效性和合規性。此外，分析技術（液相層析質譜聯用、電泳、qPCR）的進步以及外包給合約研發開發機構（CDMO）/合約研究機構（CRO）的增加，也進一步促進了市場成長。

mRNA療法和疫苗的激增

隨著新冠疫苗的成功，mRNA技術已廣泛應用，生物製藥公司正大幅拓展其在感染疾病以外的研發管線。 Moderna、BioNTech和CureVac等公司正大幅擴大生產規模和複雜性，以開發用於蛋白質替代、罕見疾病和腫瘤治療的mRNA療法。為了符合GMP和監管要求，更多批次的產品必須接受嚴格的品質監控，涵蓋完整性、純度、封蓋效率、殘留污染物等多個面向。

在全球範圍內，大規模投資正在進行中，以支持這一趨勢。為了擴大疫苗生產規模，BioNTech公司在盧安達安裝了一套模組化mRNA生產裝置（BioNTainers），並在德國馬爾堡新建了一座質體DNA生產設施。同樣，Moderna公司也在澳洲墨爾本建立了一座商業化mRNA工廠，年產能高達1億劑。 mRNA品質監測產業的發展動力源自於對先進分析工具的需求，例如液相層析-質譜聯用（LC-MS）、電泳和聚合酶鍊式反應（PCR），因為每個生產設施都必須在從原料檢驗到成品出貨的多個階段進行全面的品管檢測。

技術創新和外包趨勢

數位和分析技術的快速發展正在革新mRNA品管。新一代液相層析質譜聯用（LC-MS）系統靈敏度更高、分析時間更短，使得mRNA的精細結構分析成為可能。此外，微流體毛細管電泳技術能夠以極少的樣品量實現高通量完整性分析。次世代定序（NGS）和數位PCR（dPCR）技術也正被結合用於精確的定量和序列檢驗。這些進步推動了品質控制流程的自動化、標準化和可重複性不斷提高，從而促進mRNA生產從臨床階段到商業化生產的規模化。

同時，許多中小型生物技術公司正擴大將品質控制活動外包給合約研發生產力機構（CDMO）、合約研究機構（CRO）和專業分析實驗室。外包使這些公司避免了在設備和監管基礎設施方面的大量前期投資，同時也能獲得最尖端科技和專業知識。這一趨勢正在擴大品質控制服務供應商的目標市場，促進合作與策略夥伴關係，並支持mRNA品質監測產業產品和服務領域的成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 mRNA品質監測市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • mRNA品質監測市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章 mRNA品質監測市場：產品與服務估算及趨勢分析

  • 細分儀表板
  • 全球mRNA品質監測市場：產品與服務差異分析
  • 全球mRNA品質監測市場規模及趨勢分析（依產品/服務分類，2021-2033年）
  • 試劑盒/檢測和試劑
  • 設備和軟體
  • 品質控制測試服務

第5章 mRNA品質監測市場：技術預測與趨勢分析

  • 細分儀表板
  • 全球mRNA品質監測市場：技術差異分析
  • 全球mRNA品質監測市場規模及趨勢分析（依技術分類，2021-2033年）
  • LC-MS
  • 電泳
  • ELISA
  • PCR技術
  • 其他技術

第6章 mRNA品質監測市場：終端用戶需求預測及趨勢分析

  • 細分儀表板
  • 全球mRNA品質監測市場：最終用途變異性分析
  • 全球mRNA品質監測市場規模及趨勢分析（依最終用途分類，2021-2033年）
  • 生物製藥和生物技術公司
  • CDMO、CRO、分析實驗室
  • 學術研究機構和中心

第7章 mRNA品質監測市場：區域估算與趨勢分析

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測趨勢分析（2021-2033）：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司/競爭對手分類
  • 策略規劃
  • 企業市場分析，2024年
  • 公司簡介
    • Revvity, Inc.
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Merck KGaA
    • Waters Corporation
    • Creative Diagnostics
    • GenScript
    • TriLink BioTechnologies（Maravai LifeSciences）
    • Creative Biolabs
    • Vazyme International LLC
Product Code: GVR-4-68040-764-5

mRNA Quality Monitoring Market Summary

The global mRNA quality monitoring market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 2.33 billion by 2033, growing at a CAGR of 6.93% from 2025 to 2033. Growing adoption of mRNA-based therapeutics and vaccines drives demand for robust quality monitoring to ensure product safety, efficacy, and regulatory compliance. Furthermore, advancements in analytical technologies (LC-MS, electrophoresis, qPCR) and rising outsourcing to CDMOs/CROs further accelerate market growth.

Surge in mRNA-Based Therapeutics & Vaccines

Biopharma firms have greatly expanded their pipelines beyond infectious diseases as a result of the success of COVID-19 vaccines, which has brought mRNA into the public eye. By significantly expanding the scale and complexity of production, Moderna, BioNTech, and CureVac are developing mRNA therapies for protein replacement, rare diseases, and oncology. In order to comply with GMP and regulatory requirements, more batches must go through thorough quality monitoring, which covers integrity, purity, capping efficiency, and residual contaminants.

Globally, large capacity investments support this trend. To increase vaccine production, BioNTech is setting up modular mRNA manufacturing units (BioNTainers) in Rwanda and has constructed a new plasmid DNA manufacturing facility in Marburg, Germany. In a similar way, Moderna established a commercial mRNA plant in Melbourne, Australia, that can generate up to 100 million doses per year. The mRNA quality monitoring industry is driven by the need for sophisticated analytical tools like LC-MS, electrophoresis, and PCR because every facility needs to conduct thorough QC testing at several stages, from raw material verification to the release of the finished product.

Technology Innovation & Outsourcing Trends

Rapid advancements in digital and analytical technologies are revolutionizing the monitoring of mRNA quality. The detailed structural characterization of mRNA is now possible thanks to the increased sensitivity and quicker run times of next-generation LC-MS systems. In addition, capillary electrophoresis based on microfluidics enables high-throughput integrity analysis using small sample volumes. For accurate quantification and sequence verification, next-generation sequencing (NGS) and digital PCR (dPCR) are also combined. In order to scale mRNA manufacturing from clinical to commercial production, these developments are increasing the automation, standardization, and reproducibility of QC workflows.

In parallel, many small- and mid-sized biotech firms are increasingly outsourcing QC activities to CDMOs, CROs, and specialized analytical labs. Outsourcing allows these companies to avoid high upfront investments in instruments and regulatory compliance infrastructure, while still accessing state-of-the-art technology and expertise. This trend is expanding the addressable market for QC service providers, driving collaborations and strategic partnerships, and fueling growth across both product and service segments of the mRNA quality monitoring industry.

Global mRNA Quality Monitoring Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global mRNA quality monitoring market on the basis of product & service, technology, end use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Kits/Assays & Reagents
  • Instruments & Software
  • QC Testing Services
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • LC-MS
  • Electrophoresis
  • ELISA
  • PCR Techniques
  • Other Technologies
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical & Biotechnology Companies
  • CDMOs, CROs & Analytical Labs
  • Academic & Research Institutes/Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Technology Segment
    • 1.2.3. End Use Segment
  • 1.3. Information Analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. mRNA Quality Monitoring Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Demand for mRNA-Based Therapeutics and Vaccines
      • 3.2.1.2. Regulatory Focus on Product Safety and Consistency
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Quality Monitoring Systems
      • 3.2.2.2. Technical Complexity and Skilled Workforce Requirement
  • 3.3. MRNA quality monitoring market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. mRNA Quality Monitoring Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global mRNA Quality Monitoring Market Product & Service Movement Analysis
  • 4.3. Global mRNA Quality Monitoring Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Kits/Assays & Reagents
    • 4.4.1. Kits/Assays & reagents market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Instruments & Software
    • 4.5.1. Instruments & software market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. QC Testing Services
    • 4.6.1. QC testing services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. mRNA Quality Monitoring Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global mRNA Quality Monitoring Market Technology Movement Analysis
  • 5.3. Global mRNA Quality Monitoring Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
  • 5.4. LC-MS
    • 5.4.1. LC-MS market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Electrophoresis
    • 5.5.1. Electrophoresis market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. ELISA
    • 5.6.1. ELISA market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. PCR Techniques
    • 5.7.1. PCR techniques market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Other Technologies
    • 5.8.1. Other technologies market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. mRNA Quality Monitoring Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global mRNA Quality Monitoring Market End Use Movement Analysis
  • 6.3. Global mRNA Quality Monitoring Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Biopharmaceutical & Biotechnology Companies
    • 6.4.1. Biopharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. CDMOs, CROs & Analytical Labs
    • 6.5.1. CDMOs, CROs & analytical labs market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Academic & Research Institutes/Centers
    • 6.6.1. Academic & research institutes/centers market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. mRNA Quality Monitoring Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Competitive scenario
      • 7.4.1.3. Regulatory Framework
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory Framework
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory Framework
      • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory Framework
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory Framework
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Revvity, Inc.
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product/Service benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Agilent Technologies, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product/Service benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Bio-Rad Laboratories, Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product/Service benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product/Service benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Waters Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product/Service benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Creative Diagnostics
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product/Service benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. GenScript
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product/Service benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. TriLink BioTechnologies (Maravai LifeSciences)
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product/Service benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Creative Biolabs
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product/Service benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Vazyme International LLC
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product/Service benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global mRNA quality monitoring market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 4 Global mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 8 North America mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 9 North America mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 11 U.S. mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 12 U.S. mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 14 Canada mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 15 Canada mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 17 Mexico mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 21 Europe mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Europe mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 24 UK mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 27 Germany mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Germany mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 30 France mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 31 France mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 33 Italy mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Italy mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 36 Spain mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Spain mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 39 Denmark mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 40 Denmark mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 42 Sweden mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Sweden mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 45 Norway mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 46 Norway mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 52 China mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 53 China mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 55 Japan mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 56 Japan mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 58 India mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 59 India mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 61 South Korea mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 62 South Korea mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 64 Australia mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 65 Australia mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 67 Thailand mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 68 Thailand mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 71 Latin America mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 72 Latin America mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 74 Brazil mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 75 Brazil mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 77 Argentina mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 78 Argentina mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 79 MEA mRNA quality monitoring market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 81 MEA mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 82 MEA mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 84 South Africa mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 85 South Africa mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 90 UAE mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 91 UAE mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait mRNA quality monitoring market, by product & service, 2021 - 2033 (USD Million)
  • Table 93 Kuwait mRNA quality monitoring market, by technology, 2021 - 2033 (USD Million)
  • Table 94 Kuwait mRNA quality monitoring market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 mRNA Quality Monitoring Market: Market outlook
  • Fig. 5 mRNA Quality Monitoring Market: Segment outlook
  • Fig. 6 mRNA Quality Monitoring Market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 mRNA quality monitoring market driver impact
  • Fig. 9 mRNA quality monitoring market restraint impact
  • Fig. 10 mRNA Quality Monitoring Market: Product & service outlook and key takeaways
  • Fig. 11 mRNA Quality Monitoring Market: Product & service movement analysis
  • Fig. 12 Kits/Assays & reagents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 13 Instruments & software market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 14 QC testing services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 mRNA Quality Monitoring Market: Technology outlook and key takeaways
  • Fig. 16 mRNA Quality Monitoring Market: Technology movement analysis
  • Fig. 17 LC-MS market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Electrophoresis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 ELISA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 PCR Techniques market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Other technologies market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 mRNA Quality Monitoring Market: End use outlook and key takeaways
  • Fig. 23 mRNA Quality Monitoring Market: End use movement analysis
  • Fig. 24 Biopharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 CDMOs, CROs & analytical labs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Academic & research institutes/centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Global mRNA quality monitoring market: Regional outlook and key takeaways
  • Fig. 28 Global mRNA quality monitoring market: Regional movement analysis
  • Fig. 29 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)